Clinical Trial Update: Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial update on a composite steep-pulse treatment device for benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Composite steep-pulse treatment device

Snippet

Sponsor: REMD Medical Technology | Conditions: Benign Prostatic Hyperplasia | Phase 2, Phase 3 | Status: COMPLETED